AI Verdict
HRMY has stronger fundamentals based on our AI analysis.
HSCSW vs HRMY Fundamental Comparison
| Metric | HSCSW | HRMY |
|---|---|---|
| Revenue | $4,319.0 | $868.5M |
| Net Income | $-6.4M | $158.7M |
| Net Margin | -147,973.4% | 18.3% |
| ROE | -241.0% | 18.2% |
| ROA | -84.6% | 12.5% |
| Current Ratio | 1.19x | 3.60x |
| Debt/Equity | 0.00x | 0.19x |
| EPS | $-2.10 | $2.71 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HSCSW vs HRMY: Frequently Asked Questions
Is HSCSW or HRMY a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HRMY has stronger fundamentals. HSCSW is rated STRONG SELL (95% confidence) while HRMY is rated BUY (78% confidence). This is not investment advice.
How does HSCSW compare to HRMY fundamentally?
HeartSciences Inc. has ROE of -241.0% vs Harmony Biosciences Holdings, Inc.'s 18.2%. Net margins are -147,973.4% vs 18.3% respectively.
Which stock pays higher dividends, HSCSW or HRMY?
HSCSW has a dividend yield of N/A or no dividend while HRMY has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HSCSW or HRMY for long term?
For long-term investing, consider that HSCSW has STRONG SELL rating with 95% confidence, while HRMY has BUY rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HSCSW vs HRMY?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HSCSW vs HRMY, the AI consensus favors HRMY based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.